2 weeks Ago By Defense World Staff
Shares of Tevogen Bio Holdings Inc. ( NASDAQ:TVGN – Get Free Report ) fell 5.6% during mid-day trading on Tuesday .
The company traded as low as $1.33 and last traded at $1.34.
1,900,410 shares traded hands during trading, a decline of 62% from the average session volume of 4,968,297 shares. The stock had previously closed at $1.42.
Tevogen Bio Stock Down 5.6 % The company has a 50 day moving average price of $1.24 and a 200-day moving average price of $0.
89. Insiders Place Their Bets In other Tevogen Bio news, insider Neal Flomenberg sold 1,078,600 shares of the company’s stock in a transaction on Thursday, October 17th. The stock was sold at an average price of $1.
62, for a total value of $1,747,332.00. Following the transaction, the insider now owns 4,254,302 shares of the company’s stock, valued at approximately $6,891,969.
24. This represents a 20.23 % decrease in their ownership of the stock.
The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink . 56.60% of the stock is currently owned by insiders.
Institutional Inflows and Outflows About Tevogen Bio ( Get Free Report ) Tevogen Bio Holdings Inc operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients. Recommended Stories Five stocks we like better than Tevogen Bio Buy P&G Now, Before It Sets A New All-Time High Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor Low PE Growth Stocks: Unlocking Investment Opportunities Why Warren Buffett Is Selling: A Look at His Latest Market Moves What is the Euro STOXX 50 Index? Why Amazon Shares May Never Trade Below $200 Again Receive News & Ratings for Tevogen Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tevogen Bio and related companies with MarketBeat.
com's FREE daily email newsletter ..
